News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Regeneron Pharmaceuticals, Inc. (REGN) to Add 300 Jobs in New York


11/14/2012 7:56:54 AM

Regeneron Pharmaceuticals Inc. will add 300 jobs to its drug-production operations in East Greenbush, the company and Gov. Andrew Cuomo announced Tuesday night. The expansion builds off early success Regeneron has realized with Eylea, a drug to treat macular degeneration, which leads to blindness. The $70 million investment builds upon expansion plans Regeneron (Nasdaq: REGN) began pursuing with the town starting in the summer, and first reported by The Business Review. Cuomo called it the largest announced biotech expansion in the state this year. Regeneron's plans call for 65,000 square feet of new space for clinical trials and commercialization, as well as new office space. It will be a multi-year expansion that is projected to increase head count by 55 percent, to about 840 people.

Read at News Release
Read at Wall Street Journal
Read at Times Union


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES